Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

2004716 citationsJournal Articlebronze Open Access

Authors

To the authors' knowledge, zoledronic acid is the first bisphosphonate to demonstrate long-term safety and efficacy in this patient population.

Good health and well-being

Published in: Cancer

Volume 100, Issue 12, pp. 2613-2621

Field-Weighted Citation Impact: 15.25